Skip to content

Relationship between MR signal quantification and HIFUa efficacy in adenomyosis

Relationship between MR signal quantification and HIFUa efficacy in adenomyosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050655
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Case series:No

Sponsors

Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. 18 years of age or older, premenopausal women; 2. Clinical manifestations are dysmenorrhea/increased menstrual volume of varying degrees; 3. Complete and consistent medical history and magnetic resonance examination data;

Exclusion criteria

Exclusion criteria: 1. Incomplete medical history and auxiliary examination data; 2. Magnetic resonance acquisition parameters are inconsistent; 3. Patients with uterine fibroids; 4. Patients with infectious diseases or other neoplastic diseases;

Design outcomes

Primary

MeasureTime frame
Non-perfused volume ratio;Energy efficiency factor;

Countries

China

Contacts

Public ContactChen Jinyun

Chongqing Medical University

chenjinyun2006@126.com+86 13668029697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026